IP Portfolio

TGRx currently has two issued patents and 19 patents pending both in the United States and abroad. The company understands and has had extensive experience in the need of protecting the technology to maximize value. To that end, TGRx has retained as its patent counsel, Kilpatrick Stockton, LLP, one of the most respected intellectual property firms in the biotechnology sector.